Apellis Pharmaceuticals
APLS
APLS
99 hedge funds and large institutions have $1.03B invested in Apellis Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $1.9M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7.28% less ownership
Funds ownership: 71.28% → 64% (-7.3%)
Holders
99
Holding in Top 10
3
Calls
$1.91M
Puts
$1.9M
Top Buyers
| 1 | +$32.1M | |
| 2 | +$19.8M | |
| 3 | +$15.9M | |
| 4 |
Jennison Associates
New York
|
+$8.51M |
| 5 |
Goldman Sachs
New York
|
+$5.66M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$16.1M | |
| 3 | -$13.3M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$8.85M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.69M |